Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies.
Open Access
- 1 June 1990
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 171 (6), 1943-1955
- https://doi.org/10.1084/jem.171.6.1943
Abstract
Experimental allergic encephalomyelitis (EAE) is a model system for T cell-mediated autoimmune disease. Symptoms of EAE are similar to those of multiple sclerosis (MS) in humans. EAE is induced in susceptible animal strains by immunization with myelin basic protein (MBP) and potent adjuvant. The major T cell response to MBP in B10.PL mice is directed towards an NH2-terminal epitope and involves T cells expressing either V beta 8.2 or V beta 13 gene segments. Animals treated with a TCR V beta 8-specific mAb have a reduced incidence of EAE. We report here that the in vivo administration of a combination of anti-V beta 8.2 and anti-V beta 13 mAbs results in a long-term elimination of T cells involved in the response to MBP. When given before MBP immunization, anti-TCR antibody treatment leads to nearly complete protection against EAE. Antibody treatment also results in a dramatic reversal of paralysis in diseased animals. Thus, treatment with a combination of V beta-specific antibodies is a very effective therapy for the prevention and treatment of EAE. It is hoped that the future characterization of TCR V gene usage in human autoimmune diseases may lead to similar strategies of immune intervention.Keywords
This publication has 30 references indexed in Scilit:
- Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapyCell, 1989
- Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein.The Journal of Experimental Medicine, 1988
- Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapyCell, 1988
- Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune interventionCell, 1988
- Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouseCellular Immunology, 1986
- Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes.The Journal of Experimental Medicine, 1983
- Autoimmune Encephalomyelitis: Simultaneous Identification of T and B Cells in the Target OrganScience, 1981
- The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitisEuropean Journal of Immunology, 1981
- Autoimmune effector cells: I. Transfer of experimental allergic encephalomyelitis with lymphoid cells cultured with antigenEuropean Journal of Immunology, 1980
- Chronic relapsing experimental allergic encephalomyelitis: An experimental model of multiple sclerosisAnnals of Neurology, 1977